<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T09:24:29Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:5384138" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:5384138</identifier>
        <datestamp>2017-04-12</datestamp>
        <setSpec>bmcendi</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">BMC Endocr Disord</journal-id>
              <journal-id journal-id-type="iso-abbrev">BMC Endocr Disord</journal-id>
              <journal-title-group>
                <journal-title>BMC Endocrine Disorders</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1472-6823</issn>
              <publisher>
                <publisher-name>BioMed Central</publisher-name>
                <publisher-loc>London</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC5384138</article-id>
              <article-id pub-id-type="pmcid">PMC5384138</article-id>
              <article-id pub-id-type="pmc-uid">5384138</article-id>
              <article-id pub-id-type="pmid">28388897</article-id>
              <article-id pub-id-type="publisher-id">173</article-id>
              <article-id pub-id-type="doi">10.1186/s12902-017-0173-7</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Study Protocol</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Does left ventricular hypertrophy affect cognition and brain structural integrity in type 2 diabetes? Study design and rationale of the Diabetes and Dementia (D2) study</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Patel</surname>
                    <given-names>Sheila K.</given-names>
                  </name>
                  <address>
                    <email>skpatel@unimelb.edu.au</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Restrepo</surname>
                    <given-names>Carolina</given-names>
                  </name>
                  <address>
                    <email>carolina.restrepo@florey.edu.au</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Werden</surname>
                    <given-names>Emilio</given-names>
                  </name>
                  <address>
                    <email>ewerden@florey.edu.au</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Churilov</surname>
                    <given-names>Leonid</given-names>
                  </name>
                  <address>
                    <email>leonidc@unimelb.edu.au</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ekinci</surname>
                    <given-names>Elif I.</given-names>
                  </name>
                  <address>
                    <email>elif.ekinci@unimelb.edu.au</email>
                  </address>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Srivastava</surname>
                    <given-names>Piyush M.</given-names>
                  </name>
                  <address>
                    <email>piyush.srivastava@austin.org.au</email>
                  </address>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ramchand</surname>
                    <given-names>Jay</given-names>
                  </name>
                  <address>
                    <email>jay.ramchand@unimelb.edu.au</email>
                  </address>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Wai</surname>
                    <given-names>Bryan</given-names>
                  </name>
                  <address>
                    <email>bryan_wai@hotmail.com</email>
                  </address>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Chambers</surname>
                    <given-names>Brian</given-names>
                  </name>
                  <address>
                    <email>Brian.Chambers@austin.org.au</email>
                  </address>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                  <xref ref-type="aff" rid="Aff5">5</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>O’Callaghan</surname>
                    <given-names>Christopher J.</given-names>
                  </name>
                  <address>
                    <email>christopher.o'callaghan@austin.org.au</email>
                  </address>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                  <xref ref-type="aff" rid="Aff6">6</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Darby</surname>
                    <given-names>David</given-names>
                  </name>
                  <address>
                    <email>ddarby@unimelb.edu.au</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hachinski</surname>
                    <given-names>Vladimir</given-names>
                  </name>
                  <address>
                    <email>vladimir.hachinski@lhsc.on.ca</email>
                  </address>
                  <xref ref-type="aff" rid="Aff7">7</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Cumming</surname>
                    <given-names>Toby</given-names>
                  </name>
                  <address>
                    <email>tcumming@unimelb.edu.au</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Donnan</surname>
                    <given-names>Geoff</given-names>
                  </name>
                  <address>
                    <email>geoffrey.donnan@florey.edu.au</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes" equal-contrib="yes">
                  <name>
                    <surname>Burrell</surname>
                    <given-names>Louise M.</given-names>
                  </name>
                  <address>
                    <phone>+61 3 9496 2362</phone>
                    <email>l.burrell@unimelb.edu.au</email>
                  </address>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes" equal-contrib="yes">
                  <name>
                    <surname>Brodtmann</surname>
                    <given-names>Amy</given-names>
                  </name>
                  <address>
                    <phone>+61 (3) 9035 7004</phone>
                    <email>agbrod@unimelb.edu.au</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                  <xref ref-type="aff" rid="Aff5">5</xref>
                </contrib>
                <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.410678.c</institution-id><institution>The Florey Institute of Neuroscience and Mental Health, Melbourne Brain Centre, </institution><institution>Austin Health, </institution></institution-wrap>245 Burgundy Street, Heidelberg, VIC 3084 Australia </aff>
                <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.1008.9</institution-id><institution>Department of Medicine, </institution><institution>University of Melbourne, Austin Health, </institution></institution-wrap>Level 7, Lance Townsend Building, 145 Studley Road, Heidelberg, VIC 3084 Australia </aff>
                <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.410678.c</institution-id><institution/><institution>Austin Health Endocrine Centre, </institution></institution-wrap>Heidelberg, VIC Australia </aff>
                <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.410678.c</institution-id><institution>Department of Cardiology, </institution><institution>Austin Health, </institution></institution-wrap>Heidelberg, VIC Australia </aff>
                <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.410678.c</institution-id><institution>Department of Neurology, </institution><institution>Austin Health, </institution></institution-wrap>Heidelberg, VIC Australia </aff>
                <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.410678.c</institution-id><institution>Department of Clinical Pharmacology, </institution><institution>Austin Health, </institution></institution-wrap>Heidelberg, VIC Australia </aff>
                <aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.39381.30</institution-id><institution>Department of Clinical Neurological Sciences, London Health Sciences Centre, </institution><institution>University of Western Ontario, </institution></institution-wrap>London, Canada </aff>
              </contrib-group>
              <pub-date pub-type="epub">
                <day>7</day>
                <month>4</month>
                <year>2017</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>7</day>
                <month>4</month>
                <year>2017</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2017</year>
              </pub-date>
              <volume>17</volume>
              <elocation-id>24</elocation-id>
              <history>
                <date date-type="received">
                  <day>16</day>
                  <month>3</month>
                  <year>2017</year>
                </date>
                <date date-type="accepted">
                  <day>31</day>
                  <month>3</month>
                  <year>2017</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© The Author(s). 2017</copyright-statement>
                <license license-type="OpenAccess">
                  <license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
                </license>
              </permissions>
              <abstract id="Abs1">
                <sec>
                  <title>Background</title>
                  <p>Cognitive impairment is common in type 2 diabetes mellitus, and there is a strong association between type 2 diabetes and Alzheimer’s disease. However, we do not know which type 2 diabetes patients will dement or which biomarkers predict cognitive decline. Left ventricular hypertrophy (LVH) is potentially such a marker. LVH is highly prevalent in type 2 diabetes and is a strong, independent predictor of cardiovascular events. To date, no studies have investigated the association between LVH and cognitive decline in type 2 diabetes. The Diabetes and Dementia (D2) study is designed to establish whether patients with type 2 diabetes and LVH have increased rates of brain atrophy and cognitive decline.</p>
                </sec>
                <sec>
                  <title>Methods</title>
                  <p>The D2 study is a single centre, observational, longitudinal case control study that will follow 168 adult patients aged &gt;50 years with type 2 diabetes: 50% with LVH (case) and 50% without LVH (control). It will assess change in cardiovascular risk, brain imaging and neuropsychological testing between two time-points, baseline (0 months) and 24 months. The primary outcome is brain volume change at 24 months. The co-primary outcome is the presence of cognitive decline at 24 months. The secondary outcome is change in left ventricular mass associated with brain atrophy and cognitive decline at 24 months.</p>
                </sec>
                <sec>
                  <title>Discussion</title>
                  <p>The D2 study will test the hypothesis that patients with type 2 diabetes and LVH will exhibit greater brain atrophy than those without LVH. An understanding of whether LVH contributes to cognitive decline, and in which patients, will allow us to identify patients at particular risk.</p>
                </sec>
                <sec>
                  <title>Trial registration</title>
                  <p>Australian New Zealand Clinical Trials Registry (<ext-link ext-link-type="uri" xlink:href="https://www.australianclinicaltrials.gov.au/anzctr/trial/ACTRN12616000546459">ACTRN12616000546459</ext-link>), date registered, 28/04/2016</p>
                </sec>
                <sec>
                  <title>Electronic supplementary material</title>
                  <p>The online version of this article (doi:10.1186/s12902-017-0173-7) contains supplementary material, which is available to authorized users.</p>
                </sec>
              </abstract>
              <kwd-group xml:lang="en">
                <title>Keywords</title>
                <kwd>Type 2 diabetes mellitus</kwd>
                <kwd>Dementia</kwd>
                <kwd>Alzheimer’s disease</kwd>
                <kwd>Left ventricular hypertrophy</kwd>
                <kwd>Dementia</kwd>
                <kwd>Cognition</kwd>
                <kwd>D2 study</kwd>
              </kwd-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000925</institution-id>
                      <institution>National Health and Medical Research Council</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>APP1094974</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Brodtmann</surname>
                      <given-names>Amy</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
              </funding-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>issue-copyright-statement</meta-name>
                  <meta-value>© The Author(s) 2017</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <sec id="Sec1">
              <title>Background</title>
              <p>Type 2 diabetes mellitus is associated with an increased risk of dementia [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>] and more specifically, a two-fold increase in the risk of Alzheimer’s disease [<xref ref-type="bibr" rid="CR3">3</xref>]. Many factors may contribute to this strong association, including increased stroke incidence, white matter microstructural changes, hyperinsulinaemia and metabolic syndrome, as well as the cross-association of mid-life obesity and type 2 diabetes [<xref ref-type="bibr" rid="CR4">4</xref>]. A diagnosis of diabetes in midlife increases the risk of both vascular cognitive impairment and Alzheimer’s disease [<xref ref-type="bibr" rid="CR5">5</xref>].</p>
              <p>Magnetic resonance imaging (MRI) markers of structural brain aging such as reduced total brain volume, cortical thickness, hippocampal volume, and increasing white matter hyperintensity load, are correlated with performance on neuropsychological tests and are powerful predictors of dementia [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. A strong association between midlife vascular risk factors and structural brain aging has been demonstrated [<xref ref-type="bibr" rid="CR8">8</xref>], although longitudinal brain volume changes have not been thoroughly examined in patients with type 2 diabetes. The PROSPER study findings suggested that elderly non-demented patients with type 2 diabetes had accelerated progression of brain atrophy compared to non-diabetic individuals and provided evidence for the hypothesis that diabetes exerts deleterious effects on neuronal integrity [<xref ref-type="bibr" rid="CR9">9</xref>].</p>
              <p>There is little evidence that intensive glycaemic management as reflected by lower HbA<sub>1c</sub> levels in type 2 diabetes is associated with reduced dementia risk [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>] or cognitive decline [<xref ref-type="bibr" rid="CR12">12</xref>]. The ACCORD-MIND study investigators [<xref ref-type="bibr" rid="CR10">10</xref>] found no evidence that an intensive glycaemic treatment strategy targeting HbA<sub>1c</sub> to &lt;6% altered cognitive outcomes in patients with type 2 diabetes. However, the ACCORD study was halted due to higher mortality rates from cardiovascular events in the intensive arm [<xref ref-type="bibr" rid="CR13">13</xref>]. Subsequent follow-up of the ACCORD-MIND participants found an association between poor cognitive function and the risk of severe hypoglycaemic events [<xref ref-type="bibr" rid="CR14">14</xref>]. A further 80 months of follow-up in the ACCORDION MIND trial showed no long term benefits of intensive glycaemic control on cognition or brain MRI outcomes [<xref ref-type="bibr" rid="CR15">15</xref>]. It therefore remains unclear if tight glycaemic control as reflected by lower HbA<sub>1c</sub> levels lead to lower risk of dementia and better biomarkers are needed for the prediction of cognitive decline to stratify the risk of dementia in type 2 diabetes.</p>
              <p>Patients with type 2 diabetes have associated hypertension [<xref ref-type="bibr" rid="CR16">16</xref>], a high prevalence of previously unknown heart failure [<xref ref-type="bibr" rid="CR17">17</xref>] and left ventricular dysfunction [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. Left ventricular hypertrophy (LVH) is also highly prevalent in patients with type 2 diabetes [<xref ref-type="bibr" rid="CR18">18</xref>] and hypertension [<xref ref-type="bibr" rid="CR19">19</xref>] and is an established independent predictor of adverse cardiovascular outcomes, including stroke [<xref ref-type="bibr" rid="CR20">20</xref>] and heart failure [<xref ref-type="bibr" rid="CR21">21</xref>]. Patients with type 2 diabetes and co-morbid hypertension have increased left ventricular mass, more concentric left ventricular geometry, lower myocardial function, that is independent of age, sex, body size, arterial blood pressure and atherosclerosis, compared to hypertensive individuals without type 2 diabetes [<xref ref-type="bibr" rid="CR16">16</xref>]. Diabetes and hypertension predispose to the ischemic small vessel disease underlying lacunar infarction. Lacunar infarction can result in cognitive decline from selective damage to frontal-subcortical circuits subserving processing speed and executive function, and these deficits are often observed in type 2 diabetes [<xref ref-type="bibr" rid="CR22">22</xref>].</p>
              <p>There is a strong association between cardiac disease and impairment across many cognitive domains, particularly in tests of executive function [<xref ref-type="bibr" rid="CR23">23</xref>]. Heart failure is strongly associated with cognitive impairment [<xref ref-type="bibr" rid="CR24">24</xref>–<xref ref-type="bibr" rid="CR26">26</xref>] and is an independent risk factor for the development of Alzheimer’s disease and cerebrovascular disease [<xref ref-type="bibr" rid="CR16">16</xref>]. Carotid atherosclerosis is associated with cognitive impairment [<xref ref-type="bibr" rid="CR27">27</xref>], measures of structural brain aging [<xref ref-type="bibr" rid="CR8">8</xref>] and reductions in parietal gray matter [<xref ref-type="bibr" rid="CR8">8</xref>]. LVH is associated with progressive cognitive decline, independent of blood pressure and large artery stiffness [<xref ref-type="bibr" rid="CR28">28</xref>]. Left ventricular mass is associated with worse performance on tests of both visuospatial and verbal memory [<xref ref-type="bibr" rid="CR29">29</xref>], and there is a nonlinear association between left ventricular ejection fraction (EF) and measures of accelerated structural and cognitive brain aging [<xref ref-type="bibr" rid="CR30">30</xref>].</p>
              <sec id="Sec2">
                <title>The D2 (diabetes and dementia) study</title>
                <p>The diabetes and dementia study (D2) study is an observational study in which we will intensively study the cardiovascular status of patients with type 2 diabetes and investigate if LVH predicts cognitive function, or if specific cardiac indices predict cognitive decline and brain atrophy. We will recruit participants with type 2 diabetes and integrate transthoracic echocardiography, carotid imaging, brain imaging with MRI, circulating and genetic biomarkers, and neuropsychology tools, to establish the relationship between type 2 diabetes, brain atrophy, and cognitive decline in a cohort of 168 individuals with and without LVH. At baseline, all participants will have structural neuroimaging with MRI to assess global brain volume, regional cortical thickness and hippocampal volume, a 12 lead electrocardiogram (ECG), an echocardiogram to assess the absence or presence of LVH, a carotid ultrasound to assess vascular disease, 24-h ambulatory blood pressure and ECG, cognitive assessment, and apolipoprotein E (<italic>APOE</italic>) gene risk assessment. All of the aforementioned assessment tools will be repeated at the 24-month follow up period.</p>
              </sec>
            </sec>
            <sec id="Sec3">
              <title>Methods</title>
              <p>The D2 study has been approved by the Human Research Ethics Committee at Austin Health (HREC/15/Austin/490) and is registered at the Australian New Zealand Clinical Trials Registry (ACTRN12616000546459). Funding is provided through the National Health and Medical Research Council of Australia (APP1094974). Informed written consent is obtained from the participants prior to any data collection.</p>
              <sec id="Sec4">
                <title>D2 Study design</title>
                <p>The D2 study is a single center, observational, longitudinal, case-control study. One hundred and sixty-eight adult patients, aged greater than 50 years with type 2 diabetes will be followed: 50% with LVH (case) and 50% without (control). Patients will be assessed at baseline (0 months) and will return for tests at the 24 month time-point. Based on recruitment in our other diabetes, cognitive and imaging trials, it is expected that 80–90 patients will be recruited annually for the first 2 years. Recruitment of new patients will be completed at the end of 2 years, allowing the next 2 years for follow-up.</p>
              </sec>
              <sec id="Sec5">
                <title>Study hypotheses</title>
                <p>
                  <list list-type="order">
                    <list-item>
                      <p>Patients with type 2 diabetes and LVH will exhibit greater brain atrophy as assessed by MRI structural changes than those without LVH.</p>
                    </list-item>
                    <list-item>
                      <p>Brain atrophy as assessed by MRI structural changes will be associated with worse cognitive performance.</p>
                    </list-item>
                    <list-item>
                      <p>Increased left ventricular mass with specific left ventricular geometric patterns will be associated with the most severe regional brain atrophy and cognitive decline.</p>
                    </list-item>
                  </list>
                </p>
              </sec>
              <sec id="Sec6">
                <title>Study aims</title>
                <p>
                  <list list-type="order">
                    <list-item>
                      <p>To establish whether diabetic patients with LVH have increased rates of brain atrophy and cognitive decline.</p>
                    </list-item>
                    <list-item>
                      <p>To establish whether the specific LV geometric measures are associated with these brain volume changes.</p>
                    </list-item>
                  </list>
                </p>
              </sec>
              <sec id="Sec7">
                <title>Study outcome measures</title>
                <p>Our primary endpoint is brain volume change at 2 years (hypothesis 1). Our co-primary outcome is the presence of cognitive decline at 2 years (hypothesis 2). We shall use advanced brain imaging to accurately measure brain volume and correlate this with cardiac echocardiography, carotid intima media thickness (CIMT), and 24 h blood pressure and ECG monitoring in 168 patients with type 2 diabetes, with longitudinal testing allowing measurement of change at 24 months. Concurrent neuropsychological testing will indicate whether the clinical profile of cognitive impairment and dementia aligns with measures of brain volume.</p>
              </sec>
              <sec id="Sec8">
                <title>Eligibility criteria</title>
                <p>Inclusion criteria are as follows: (1) aged over 50 years; (2) no prior neurological or psychiatric disease, including stroke; (3) ability to give informed consent and participate in cognitive testing. The study exclusion criteria are as follows: (1) known prior stroke, transient ischemic attack or dementia; (2) significant medical co-morbidities precluding participation in cognitive testing, or making survival for 24 months unlikely; (3) normal exclusion criteria for MRI; e.g., implanted metal, severe claustrophobia; (4) severe diabetic nephropathy: estimated glomerular filtration rate (eGFR &lt;30 mL/min/1.73 m<sup>2</sup>).</p>
              </sec>
              <sec id="Sec9">
                <title>Study assessments</title>
                <p>The schedule of assessments is provided in Table <xref rid="Tab1" ref-type="table">1</xref>. Testing will include the following: a pre-study screening questionnaire and MRI safety check to determine eligibility; demographic and medical history questionnaire; clinic measurement of height, weight, waist and hip; echocardiogram, ECG; CIMT; 24 h ambulatory blood pressure and ECG monitor; cognitive assessment; MRI scan; physical activity monitor; and a blood sample (to determine <italic>APOE</italic> genetic risk and analyses of genetic and plasma/serum biomarkers).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Schedule of assessments at baseline (0 months) and 24 months</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Assessments</th><th rowspan="2">Brief description</th><th colspan="2">Time-point (months)</th></tr><tr><th>0</th><th>24</th></tr></thead><tbody><tr><td>Pre-study screening questionnaire (to determine study eligibility)</td><td>Study eligibility criteria</td><td>✓</td><td/></tr><tr><td>MRI safety check questionnaire</td><td>MRI eligibility</td><td>✓</td><td>✓</td></tr><tr><td>Demographic and medical history questionnaire</td><td>Questionnaire completed with the study investigator</td><td>✓</td><td>✓</td></tr><tr><td>Weight, height, waist and hip measurement</td><td>Clinical assessment</td><td>✓</td><td>✓</td></tr><tr><td>Transthoracic echocardiogram</td><td>Assess cardiac structure and function</td><td>✓</td><td>✓</td></tr><tr><td>Blood sample</td><td>Plasma electrolytes, glucose, HbA<sub>1C</sub>, lipids and urinary analyses. Blood collected for <italic>APOE</italic> genotyping and assessment of other genetic and circulating biomarkers.</td><td>✓</td><td>✓</td></tr><tr><td>Carotid intimal medial thickness</td><td>B-mode ultrasound to assess left and right internal carotid arteries and the degree of stenosis</td><td>✓</td><td>✓</td></tr><tr><td>24 h ambulatory blood pressure and ECG Holter</td><td>Simultaneous measurement of blood pressure and ECG</td><td>✓</td><td>✓</td></tr><tr><td rowspan="7">MRI scanning on a Siemens 3 T Skyra scanner using a 64 Channel receive only head coil.</td><td>• High resolution isotropic T1 3D MPRAGE (structural scan)</td><td rowspan="7">✓</td><td rowspan="7">✓</td></tr><tr><td>• High resolution isotropic T2 FLAIR 3D</td></tr><tr><td>• High resolution isotropic T2 3D</td></tr><tr><td>• Susceptibility-weighted image (SWI) for iron deposition</td></tr><tr><td>• Diffusion-weighted imaging (DWI)</td></tr><tr><td>• GRE field mapping</td></tr><tr><td>• BOLD 7 min free run (resting state connectivity)</td></tr><tr><td>Cognitive and mood evaluation</td><td>Validated tools for assessing mood, global cognitive ability, attention, visuospatial ability, executive function, language, memory, processing speed</td><td>✓</td><td>✓</td></tr><tr><td>Physical activity assessment</td><td>SenseWear Armband (BodyMedia FIT)</td><td>✓</td><td>✓</td></tr></tbody></table></table-wrap>
</p>
              </sec>
              <sec id="Sec10">
                <title>Details of questionnaire and measurements</title>
                <sec id="Sec11">
                  <title>Pre-study screening and MRI safety check questionnaires</title>
                  <p>A short questionnaire will be used to ask questions related to the study eligibility, which will be key to identifying patients that may be unsuitable for MRI testing. Those identified as unsuitable will be informed at this stage and no further measurements will be conducted. Eligible participants will complete a detailed MRI safety questionnaire with the investigator to obtain more specific information about their history of surgical procedures to determine whether they have implants that might not be suitable for a 3 T MRI scan. Participants will be excluded if they cannot have a research 3 T MRI scan (e.g., because they have a metal implant that has not been cleared for safety in a 3 T MRI scanner).</p>
                </sec>
                <sec id="Sec12">
                  <title>Demographic and medical history questionnaire</title>
                  <p>A questionnaire and medical record review will be conducted at the time of the echocardiogram and blood collection. The following information will be collected: age, sex, duration of diabetes, smoking history, alcohol consumption, current drug therapy and dose, socioeconomic status family history of cardiovascular disease, medical history including general health and co-morbidities (cardiac disease, hypertension, dyslipidaemia, the presence of micro-vascular disease (nephropathy, retinopathy, neuropathy) and other macro-vascular complications (peripheral vascular disease). The questionnaire will be cross-checked by medical record review at Austin Health, and from their clinical and specialist reports if recruited outside of Austin Health.</p>
                </sec>
                <sec id="Sec13">
                  <title>Physical measurements</title>
                  <p>Participants’ height and weight (to determine body mass index (BMI) and body surface area) will be assessed. Weight will be measured to the nearest 0.1 kg on standing digital scales without shoes and light clothing. Height will be measured using a wall-mounted stadiometer to the nearest 0.1 cm. Waist and hip circumferences will be measured using a spring loaded tape. Waist circumference is measured at the mid-point between the lower costal margin and the iliac crest. Hip circumference is measured over the greater trochanters.</p>
                </sec>
                <sec id="Sec14">
                  <title>Transthoracic echocardiography (TTE)</title>
                  <p>TTE will be performed by a cardiologist using a commercially available portable ultrasound system (Vivid i, GE Healthcare). Standard parasternal and apical views will be used to assess left ventricular mass. Measurements are obtained according to the American Society of Echocardiography (ASE) recommendations [<xref ref-type="bibr" rid="CR31">31</xref>]. M-mode echo will be used to measure cardiac dimensions and wall thickness. Ejection fraction will be calculated using the modified Simpson’s rule. Left ventricular mass will be indexed using the ASE corrected convention, by dividing left ventricular mass by height<sup>2.7</sup>. LVH will be defined as &gt;49 g/m<sup>2.7</sup> for males and &gt;45 g/m<sup>2.7</sup> for females. Relative wall thickness will be calculated, and left ventricular remodelling classified as normal, eccentric, or concentric remodelling and concentric LVH.</p>
                </sec>
                <sec id="Sec15">
                  <title>Blood collection and measurements</title>
                  <p>Fasting plasma electrolytes, glucose, HbA<sub>1C</sub>, lipids and urinary analyses will be obtained on all patients at baseline and at 24 months. The D2 study will collect additional plasma, serum and whole blood for genetic analyses. The exploration of novel circulating biomarkers and genetic determinations that lead to LVH and/or brain atrophy will be conducted within our laboratory. Whole blood will be collected and divided between lithium heparin and EDTA tubes for plasma and genetic samples and a plain tube for serum. Serum will be extracted and aliquoted for storage at -80 °C until assayed. For plasma, the sample tube will be stored on ice and centrifuged within 15 min to separate the plasma. The plasma will be aliquoted for storage at -80 °C until assayed. Whole blood will be collected in a potassium EDTA tube and immediately stored at -80 °C until DNA extraction. <italic>APOE</italic> genotyping will be performed in our laboratory. Genomic DNA will be extracted using the Qiagen DNA Maxi kit (Qiagen, Germany) and the <italic>APOE</italic> region of interest will be amplified with specific primers. The resulting DNA fragment will be sequenced in the forward and reverse direction on an ABI 3130-xl genetic analyser (Applied Biosystems, CA, USA). Participants will be informed of their <italic>APOE</italic> ε4 status by the Principle Investigator and those with <italic>APOE</italic> ε4 homozygosity will be offered counselling via the Neurogenetics Clinic at Austin Health.</p>
                </sec>
                <sec id="Sec16">
                  <title>Carotid Doppler ultrasound</title>
                  <p>CIMT measurements will be conducted in the Neurology diagnostics laboratory, Austin Health by a single technician. High-resolution B-mode ultrasound images will be obtained on both right and left internal carotid arteries. CIMT will be measured, and the degree of stenosis will also be classified into accepted clinical grades for incorporation into multivariate analyses: none, &lt;50%, 50–69%, 70–79%, 80–89%, 90–99% and occluded (NASCET criteria) [<xref ref-type="bibr" rid="CR32">32</xref>].</p>
                </sec>
                <sec id="Sec17">
                  <title>Ambulatory blood pressure and ECG monitoring</title>
                  <p>Each participant will have a combined Holter monitor simultaneously assessing ambulatory blood pressure and ECG data (CardXplore, Meditech, Hungary).</p>
                </sec>
                <sec id="Sec18">
                  <title>MRI acquisition and processing</title>
                  <p>Scans will be acquired for gray and white matter anatomical, structural and functional connectivity and iron estimation analyses. High resolution structural MRI of study subjects will be acquired using a 3 T Siemens Skyra MR scanner. The following sequences will be acquired: T1-weighted three-dimension (3D) magnetization-prepared rapid gradient-echo (MP-RAGE) for anatomical analyses; susceptibility-weighted image (SWI) for iron estimation and microhemorrhage imaging; fluid-attenuated inversion recovery (FLAIR) to assess chronic white matter ischemic changes and diffusion weighted imaging (DWI) to assess white matter structural integrity.</p>
                  <p>Regional cortical gray matter atrophy will be assessed using vertex-wise cortical thickness analysis. Cortical thickness will be mapped using the FreeSurfer software package for analysis of structural MRI data (<ext-link ext-link-type="uri" xlink:href="http://surfer.nmr.mgh.harvard.edu/fswiki">http://surfer.nmr.mgh.harvard.edu/fswiki</ext-link>) [<xref ref-type="bibr" rid="CR33">33</xref>]. The automated cortical and subcortical parcellation routines also provided with FreeSurfer will be used to investigate regional volume changes. We will use processing streams developed specifically by our group for longitudinal studies [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>]. Hippocampal volume changes will be assessed using manual hippocampal segmentation. Iron deposition and cerebral microbleeds will be assessed with susceptibility-weighted image analyses. The MRI protocol is provided in the Additional file <xref rid="MOESM1" ref-type="media">1</xref>.</p>
                </sec>
                <sec id="Sec19">
                  <title>Cognitive and mood assessment questionnaire and tests</title>
                  <p>Participants will complete a neuropsychological assessment. The assessment will include several paper-and-pencil and computerized cognitive tasks and mood questionnaires. Six cognitive domains will be examined, including (i) attention, (ii) visuospatial ability, (iii) executive function, (iv) language, (v) memory, and (vi) processing speed. The tasks used to measure each cognitive domain are listed in Table <xref rid="Tab2" ref-type="table">2</xref>. This protocol has been modelled on that validated by the CANVAS study, a longitudinal study of patients after stroke [<xref ref-type="bibr" rid="CR36">36</xref>]. All tasks are designed for serial testing and are less affected by practice effects. Performance on individual cognitive tests will be standardised using established norms and domain scores will be calculated by averaging the standardised scores from each contributing test (e.g., Trail Making Test as a measure of attention). Assessment of mood will be completed using the seven-item Generalized Anxiety Disorder (GAD-7) questionnaire and the nine-item Patient Health Questionnaire (PHQ-9). These questionnaires are based on criteria for the diagnosis of generalised anxiety and depression (Diagnostic and Statistical Manual-Fourth Edition: DSM-V) [<xref ref-type="bibr" rid="CR37">37</xref>].<table-wrap id="Tab2"><label>Table 2</label><caption><p>Tasks used to measure each cognitive domain</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Cognitive domain</th><th>Cognitive task</th></tr></thead><tbody><tr><td rowspan="3">Global Cognitive Ability</td><td>Montreal Cognitive Assessment [<xref ref-type="bibr" rid="CR45">45</xref>]</td></tr><tr><td>The Clinical Dementia Rating [<xref ref-type="bibr" rid="CR46">46</xref>]</td></tr><tr><td>National Adult Reading Task [<xref ref-type="bibr" rid="CR47">47</xref>]</td></tr><tr><td rowspan="4">Attention</td><td>Trail-Making Test [<xref ref-type="bibr" rid="CR48">48</xref>]</td></tr><tr><td>Digit Span Task (WAIS-IV) [<xref ref-type="bibr" rid="CR49">49</xref>]</td></tr><tr><td>Identification Task (Computerised CogState battery) [<xref ref-type="bibr" rid="CR50">50</xref>]</td></tr><tr><td>One Back Task (Computerised) [<xref ref-type="bibr" rid="CR50">50</xref>] CogState battery)</td></tr><tr><td>Visuospatial Ability</td><td>Rey Complex Figure Test (Copy) [<xref ref-type="bibr" rid="CR51">51</xref>]</td></tr><tr><td rowspan="2">Executive Function</td><td>Clock Drawing Task – CLOX [<xref ref-type="bibr" rid="CR52">52</xref>]</td></tr><tr><td>Controlled Oral Word Association Test [<xref ref-type="bibr" rid="CR53">53</xref>]</td></tr><tr><td rowspan="2">Language</td><td>30-item Boston Naming Test [<xref ref-type="bibr" rid="CR54">54</xref>]</td></tr><tr><td>Verbal Fluency Test [<xref ref-type="bibr" rid="CR53">53</xref>]</td></tr><tr><td rowspan="2">Memory</td><td>Rey Auditory Verbal learning Task [<xref ref-type="bibr" rid="CR55">55</xref>]</td></tr><tr><td>Rey Complex Figure Test (Recall) [<xref ref-type="bibr" rid="CR51">51</xref>]</td></tr><tr><td rowspan="2">Processing Speed</td><td>Detection Task (Computerized CogState battery) [<xref ref-type="bibr" rid="CR50">50</xref>]</td></tr><tr><td>Digit-Symbol Task (WAIS-IV) [<xref ref-type="bibr" rid="CR49">49</xref>]</td></tr></tbody></table></table-wrap>
</p>
                </sec>
                <sec id="Sec20">
                  <title>Physical activity monitoring</title>
                  <p>The SenseWear Pro2 Armband (HealthWear BodyMedia, Pittsburgh, PA, USA) is a portable device which enables monitoring of energy expenditure and activity. The device uses a two-axis accelerometer, a heat flux sensor, a galvanic skin response sensor, a skin temperature sensor, and a near-body ambient temperature sensor to capture data and will be worn by each participant on the upper arm for 7 days. The data will be converted into Metabolic Equivalents minutes (METs*minutes) and energy expenditure using an algorithm (Bodymedia, Sense Wear 6.1) [<xref ref-type="bibr" rid="CR38">38</xref>]. The SenseWear monitor has been validated for measuring energy expenditure in diabetes against double-labeled water [<xref ref-type="bibr" rid="CR39">39</xref>].</p>
                </sec>
              </sec>
              <sec id="Sec21">
                <title>Sample size</title>
                <p>We aim to recruit 168 patients with type 2 diabetes. Patients will be divided based on the presence of LVH. Higher left ventricular mass and concentric geometric changes have been demonstrated in approximately 35–40% of patients with type 2 diabetes [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. Our data suggested more than 50% of participants will have LVH [<xref ref-type="bibr" rid="CR18">18</xref>]. We calculated our sample size in order to include sufficient participant numbers for both the primary endpoint comparison (brain volume) and for the primary outcome measure (presence of cognitive impairment). The primary endpoint requires a direct comparison of two groups: type 2 diabetes patients with LVH and those without. We based our effect size on published brain volume and cortical thickness estimates performed on healthy controls, cerebrovascular disease patients and Alzheimer’s disease patients [<xref ref-type="bibr" rid="CR40">40</xref>–<xref ref-type="bibr" rid="CR42">42</xref>], and prior imaging of healthy controls and stroke patients performed by our group [<xref ref-type="bibr" rid="CR43">43</xref>]. We use an average brain volume change of &lt;0.5% per annum for controls, 1–2% for cerebrovascular disease, and 2–4% for dementia [<xref ref-type="bibr" rid="CR44">44</xref>].</p>
                <p>We used a modified retrospective case-control method. All participants have the exposure (type 2 diabetes), which will naturally halve by the additional risk factor (LVH, expected prevalence around 50%), but only some of them will develop the primary outcome (cognitive decline). We used an ANCOVA method to estimate sample size for four samples (cognitively impaired LVH, non-cognitively impaired LVH, cognitively impaired non-LVH, non-cognitively impaired non-LVH) with repeated measures, including a correlation score between baseline and follow-up. Using alpha = 0.05 (two-sided), power = 0.8 and an estimated correlation of 0.1, we estimated that 140 (i.e., 35 in each of 4 groups) participants will be required. Given we expect around 20% attrition due to death or non-participation (unable to participate in testing due to new pacemaker/implanted metal/other medical issue, lost to contact, no longer interested), we have estimated a total recruitment number of 168. This model has used the conservative estimates from these results and assumes the following: that 30% of patients will be cognitively impaired at 2 years; a 1% total annual brain volume change for patients with type 2 diabetes; that 30% of patients will exhibit specific left ventricular geometric changes; and a low correlation between baseline and follow-up measures.</p>
              </sec>
              <sec id="Sec22">
                <title>Statistical analysis</title>
                <p>The analysis of this study will be performed in three parts as follows.<list list-type="bullet"><list-item><p><bold><italic>Hypothesis 1: comparing brain volumes between participants with and without LVH</italic></bold>. Independent samples t-tests will be used to determine differences between participants with and without LVH at each time-point. Repeated-measures t-tests will be used to determine the extent of brain volume loss across the two time-points. These results will be compared between groups. In the cortical thickness analyses, the large number of statistical inferences being carried out across the cortical sheet (approximately 160,000 vertices per hemisphere) requires adjustment of the statistical threshold. This is to control for the increased number of false positive findings using false discovery rate correction procedure widely used for cortical thickness analyses. In the volumetric analyses, total brain volume, regional white matter, cortical and subcortical volume changes will be modelled using a repeated measures design. Intracranial volume, which is determined partially by gender and race, is a known confounding factor that contributes to regional brain volumes. This will be controlled for in the statistical analysis of regional brain volume change. We have demonstrated this to be a reliable index of brain volume in previous studies [<xref ref-type="bibr" rid="CR43">43</xref>].</p></list-item><list-item><p><bold><italic>Hypothesis 2: correlating brain volume with cognitive performance.</italic></bold> The initial regressive analysis will examine differences between cognitively impaired and normal participants at 2 years. We will correlate both global and regional measures of brain volume with the groups. Global brain and regional hippocampal volumes, and mean regional cortical thickness values for the stated regions of interest will be compared between two groups, in order to correlate LVH-associated brain volume changes with cognition. We will also perform a multivariate analysis across the cohort as a whole to investigate whether there is a dose-related association with any extent of cardiac impairment. Multivariate regression will be conducted to determine whether brain volume loss correlates with the presence or absence of cognitive impairment, adjusting for known important variables such as age, years of education, CIMT, atrial fibrillation, cholesterol and hypertension, as well as potentially relevant variables including <italic>APOE</italic> ε4 status, cardiac indices such as stroke volume, renal function and HbA<sub>1c</sub> levels.</p></list-item><list-item><p><bold><italic>Hypothesis 3: comparing brain volume and cognitive performance in participants with increased left ventricular mass and specific left ventricular geometric patterns.</italic></bold> Analysis will be similar to that for LVH, except that patients will be divided on the presence or absence of specific morphometric measures. That is, analyses will be performed at each time-point (cross-sectional), and also longitudinally, to investigate change across time. Repeated-measures t-tests will determine the extent of brain volume loss across the two time-points and compared between groups. Correlation with cognitive performance will be performed as above. Unadjusted differences for clinical variables between groups will be assessed by <italic>t</italic>-test. Difference in laboratory data and left ventricular systolic function will be adjusted for age and sex by use of ANCOVA. Differences in left ventricular structure and geometry will be adjusted for age, sex, BMI, and systolic blood pressure as their major established covariates with further adjustment for duration of hypertension. Fisher’s Exact Test and odds ratios will be used to test differences for categorical variables. Logistic regression analysis will be used to derive odds ratios adjusted for covariates. Multiple regression analyses will be performed to assess relation of cognitive and brain volume measures to higher left ventricular mass independent of established covariates and duration of hypertension.</p></list-item></list>
</p>
              </sec>
            </sec>
            <sec id="Sec23">
              <title>Discussion</title>
              <p>The D2 study will aim to improve the understanding of two of the major causes of death, disability and reduced quality of life in our society: diabetes and dementia. In an ageing population, it is vitally important that we increase our knowledge of the relationships between cardiovascular disease and cognition. We have the means to identify a potentially treatable risk factor in the causation of cognitive impairment. The study will provide unique information on the relationship between LVH and dementia in type 2 diabetes, and whether cardiac structural and functional abnormalities contribute to increased brain atrophy and cognitive impairment. Brain volume changes may precede cognitive changes, providing a potential for early diagnosis and intervention. A large proportion of these patients may have associated or superadded Alzheimer’s pathology. These patients provide a high risk cohort requiring urgent intervention to prevent increasing dependence and disability. The identification of people at risk of cognitive impairment and dementia will allow for both secondary prevention and early intervention. With the advent of aggressive risk management strategies for cardiovascular disease, identification of these patients will allow them to be treated early in their disease course, ideally before they develop cognitive decline.</p>
            </sec>
          </body>
          <back>
            <app-group>
              <app id="App1">
                <sec id="Sec24">
                  <title>Additional file</title>
                  <p>
                    <media position="anchor" xlink:href="12902_2017_173_MOESM1_ESM.docx" id="MOESM1">
                      <label>Additional file 1:</label>
                      <caption>
                        <p>D2 Study MRI: Data acquired on a Siemens 3 T Skyra scanner using a 64 Channel receive only head coil. (DOCX 12 kb)</p>
                      </caption>
                    </media>
                  </p>
                </sec>
              </app>
            </app-group>
            <glossary>
              <title>Abbreviations</title>
              <def-list>
                <def-item>
                  <term>3D</term>
                  <def>
                    <p>Three-dimension</p>
                  </def>
                </def-item>
                <def-item>
                  <term>APOE</term>
                  <def>
                    <p>Apolipoprotein E</p>
                  </def>
                </def-item>
                <def-item>
                  <term>ASE</term>
                  <def>
                    <p>American Society of Echocardiography</p>
                  </def>
                </def-item>
                <def-item>
                  <term>BMI</term>
                  <def>
                    <p>Body mass index</p>
                  </def>
                </def-item>
                <def-item>
                  <term>CIMT</term>
                  <def>
                    <p>Carotid intima media thickness</p>
                  </def>
                </def-item>
                <def-item>
                  <term>DWI</term>
                  <def>
                    <p>Diffusion weighted imaging</p>
                  </def>
                </def-item>
                <def-item>
                  <term>ECG</term>
                  <def>
                    <p>Electrocardiogram</p>
                  </def>
                </def-item>
                <def-item>
                  <term>eGFR</term>
                  <def>
                    <p>Estimated glomerular filtration rate</p>
                  </def>
                </def-item>
                <def-item>
                  <term>FLAIR</term>
                  <def>
                    <p>Fluid-attenuated inversion recovery</p>
                  </def>
                </def-item>
                <def-item>
                  <term>GAD-7</term>
                  <def>
                    <p>Generalized anxiety disorder questionnaire</p>
                  </def>
                </def-item>
                <def-item>
                  <term>LVH</term>
                  <def>
                    <p>Left ventricular hypertrophy</p>
                  </def>
                </def-item>
                <def-item>
                  <term>MET</term>
                  <def>
                    <p>Metabolic equivalents minute</p>
                  </def>
                </def-item>
                <def-item>
                  <term>MPRAGE</term>
                  <def>
                    <p>Magnetization-prepared rapid gradient-echo</p>
                  </def>
                </def-item>
                <def-item>
                  <term>MRI</term>
                  <def>
                    <p>Magnetic resonance imaging</p>
                  </def>
                </def-item>
                <def-item>
                  <term>PHQ-9</term>
                  <def>
                    <p>Patient health questionnaire</p>
                  </def>
                </def-item>
                <def-item>
                  <term>SWI</term>
                  <def>
                    <p>Susceptibility-weighted image</p>
                  </def>
                </def-item>
                <def-item>
                  <term>TTE</term>
                  <def>
                    <p>Transthoracic echocardiography</p>
                  </def>
                </def-item>
              </def-list>
            </glossary>
            <ack>
              <title>Acknowledgements</title>
              <p>We thank staff at the outpatient diabetes clinic at Austin Health for their assistance in recruiting study participants and the Florey Imaging team for conducting the MRI scans.</p>
              <sec id="FPar1">
                <title>Funding</title>
                <p>The study has been funded by the National Health and Medical Research Council of Australia (application ID, APP1094974).</p>
              </sec>
              <sec id="FPar2">
                <title>Availability of data and materials</title>
                <p>The study is currently in progress and therefore study data is not available.</p>
              </sec>
              <sec id="FPar3">
                <title>Authors’ contributions</title>
                <p>AB and LMB conceived the D2 study and obtained the funding to conduct it, and contributed to the writing of the manuscript; SKP contributed to the design of the D2 study protocol, ethics approval, and writing of the manuscript. CR contributed to the design of the D2 study protocol, cognitive testing protocol and writing of the manuscript. EW contributed to the design of the D2 study protocol, cognitive testing protocol and writing of the manuscript. LC contributed to the sample size calculations, writing of the manuscript and obtaining study funding. EIE contributed to patient recruitment and interpretation of clinical data and writing of the manuscript. PMS, JR and BW contributed to the design of the echocardiography protocol. BC contributed to the CIMT protocol. CJOC contributed to the design and collection of 24-h blood pressure and ECG data. DD designed the CogState neuropsych battery. VH contributed to the study design and obtaining study funding. TC contributed to the design of the physical activity protocol. GD contributed to the study design obtained study funding. All authors read and approved the final manuscript.</p>
              </sec>
              <sec id="FPar4">
                <title>Competing interests</title>
                <p>The authors declare that they have no competing interests.</p>
              </sec>
              <sec id="FPar5">
                <title>Consent for publication</title>
                <p>Not applicable.</p>
              </sec>
              <sec id="FPar6">
                <title>Ethics approval and consent to participate</title>
                <p>Ethics approval has been obtained from the Human Research Ethics Committee at Austin Health, Melbourne, Australia (HREC/15/Austin/490). The study is conducted in accordance with the Declaration of Helsinki. Study participation requires written informed consent before participation and data collection.</p>
              </sec>
              <sec id="FPar7">
                <title>Publisher’s Note</title>
                <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
              </sec>
            </ack>
            <ref-list id="Bib1">
              <title>References</title>
              <ref id="CR1">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Biessels</surname>
                      <given-names>GJ</given-names>
                    </name>
                    <name>
                      <surname>Staekenborg</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Brunner</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Brayne</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Scheltens</surname>
                      <given-names>P</given-names>
                    </name>
                  </person-group>
                  <article-title>Risk of dementia in diabetes mellitus: a systematic review</article-title>
                  <source>Lancet Neurol</source>
                  <year>2006</year>
                  <volume>5</volume>
                  <issue>1</issue>
                  <fpage>64</fpage>
                  <lpage>74</lpage>
                  <pub-id pub-id-type="doi">10.1016/S1474-4422(05)70284-2</pub-id>
                  <?supplied-pmid 16361024?>
                  <pub-id pub-id-type="pmid">16361024</pub-id>
                </element-citation>
              </ref>
              <ref id="CR2">
                <label>2.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Van den Berg</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Kessels</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Kappelle</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>De Haan</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Biessels</surname>
                      <given-names>G</given-names>
                    </name>
                    <collab>Group UDES</collab>
                  </person-group>
                  <article-title>Type 2 diabetes, cognitive function and dementia: vascular and metabolic determinants</article-title>
                  <source>Drugs Today (Barc)</source>
                  <year>2006</year>
                  <volume>42</volume>
                  <issue>11</issue>
                  <fpage>741</fpage>
                  <lpage>754</lpage>
                  <pub-id pub-id-type="doi">10.1358/dot.2006.42.11.1003542</pub-id>
                  <pub-id pub-id-type="pmid">17171193</pub-id>
                </element-citation>
              </ref>
              <ref id="CR3">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Scheltens</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Fox</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Barkhof</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>De Carli</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <article-title>Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion</article-title>
                  <source>Lancet Neurol</source>
                  <year>2002</year>
                  <volume>1</volume>
                  <issue>1</issue>
                  <fpage>13</fpage>
                  <lpage>21</lpage>
                  <pub-id pub-id-type="doi">10.1016/S1474-4422(02)00002-9</pub-id>
                  <?supplied-pmid 12849541?>
                  <pub-id pub-id-type="pmid">12849541</pub-id>
                </element-citation>
              </ref>
              <ref id="CR4">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kivipelto</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Helkala</surname>
                      <given-names>EL</given-names>
                    </name>
                    <name>
                      <surname>Laakso</surname>
                      <given-names>MP</given-names>
                    </name>
                    <name>
                      <surname>Hanninen</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Hallikainen</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Alhainen</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Soininen</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Tuomilehto</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Nissinen</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Midlife vascular risk factors and Alzheimer’s disease in later life: longitudinal, population based study</article-title>
                  <source>BMJ</source>
                  <year>2001</year>
                  <volume>322</volume>
                  <issue>7300</issue>
                  <fpage>1447</fpage>
                  <lpage>1451</lpage>
                  <pub-id pub-id-type="doi">10.1136/bmj.322.7300.1447</pub-id>
                  <?supplied-pmid 11408299?>
                  <pub-id pub-id-type="pmid">11408299</pub-id>
                </element-citation>
              </ref>
              <ref id="CR5">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Peila</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Rodriguez</surname>
                      <given-names>BL</given-names>
                    </name>
                    <name>
                      <surname>Launer</surname>
                      <given-names>LJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies The Honolulu-Asia Aging Study</article-title>
                  <source>Diabetes</source>
                  <year>2002</year>
                  <volume>51</volume>
                  <issue>4</issue>
                  <fpage>1256</fpage>
                  <lpage>1262</lpage>
                  <pub-id pub-id-type="doi">10.2337/diabetes.51.4.1256</pub-id>
                  <?supplied-pmid 11916953?>
                  <pub-id pub-id-type="pmid">11916953</pub-id>
                </element-citation>
              </ref>
              <ref id="CR6">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jack</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Shiung</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Weigand</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>O’Brien</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Gunter</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Boeve</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Knopman</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Smith</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Ivnik</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Tangalos</surname>
                      <given-names>E</given-names>
                    </name>
                  </person-group>
                  <article-title>Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI</article-title>
                  <source>Neurology</source>
                  <year>2005</year>
                  <volume>65</volume>
                  <issue>8</issue>
                  <fpage>1227</fpage>
                  <lpage>1231</lpage>
                  <pub-id pub-id-type="doi">10.1212/01.wnl.0000180958.22678.91</pub-id>
                  <?supplied-pmid 16247049?>
                  <pub-id pub-id-type="pmid">16247049</pub-id>
                </element-citation>
              </ref>
              <ref id="CR7">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jack</surname>
                      <given-names>CR</given-names>
                    </name>
                    <name>
                      <surname>Lowe</surname>
                      <given-names>VJ</given-names>
                    </name>
                    <name>
                      <surname>Weigand</surname>
                      <given-names>SD</given-names>
                    </name>
                    <name>
                      <surname>Wiste</surname>
                      <given-names>HJ</given-names>
                    </name>
                    <name>
                      <surname>Senjem</surname>
                      <given-names>ML</given-names>
                    </name>
                    <name>
                      <surname>Knopman</surname>
                      <given-names>DS</given-names>
                    </name>
                    <name>
                      <surname>Shiung</surname>
                      <given-names>MM</given-names>
                    </name>
                    <name>
                      <surname>Gunter</surname>
                      <given-names>JL</given-names>
                    </name>
                    <name>
                      <surname>Boeve</surname>
                      <given-names>BF</given-names>
                    </name>
                    <name>
                      <surname>Kemp</surname>
                      <given-names>BJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer’s disease: implications for sequence of pathological events in Alzheimer’s disease</article-title>
                  <source>Brain</source>
                  <year>2009</year>
                  <volume>132</volume>
                  <issue>5</issue>
                  <fpage>1355</fpage>
                  <lpage>1365</lpage>
                  <pub-id pub-id-type="doi">10.1093/brain/awp062</pub-id>
                  <?supplied-pmid 19339253?>
                  <pub-id pub-id-type="pmid">19339253</pub-id>
                </element-citation>
              </ref>
              <ref id="CR8">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cardenas</surname>
                      <given-names>VA</given-names>
                    </name>
                    <name>
                      <surname>Reed</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Chao</surname>
                      <given-names>LL</given-names>
                    </name>
                    <name>
                      <surname>Chui</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Sanossian</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>DeCarli</surname>
                      <given-names>CC</given-names>
                    </name>
                    <name>
                      <surname>Mack</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Kramer</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Hodis</surname>
                      <given-names>HN</given-names>
                    </name>
                    <name>
                      <surname>Yan</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Associations among vascular risk factors, carotid atherosclerosis, and cortical volume and thickness in older adults</article-title>
                  <source>Stroke</source>
                  <year>2012</year>
                  <volume>43</volume>
                  <issue>11</issue>
                  <fpage>2865</fpage>
                  <lpage>2870</lpage>
                  <pub-id pub-id-type="doi">10.1161/STROKEAHA.112.659722</pub-id>
                  <?supplied-pmid 22984010?>
                  <pub-id pub-id-type="pmid">22984010</pub-id>
                </element-citation>
              </ref>
              <ref id="CR9">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>van Elderen</surname>
                      <given-names>SG</given-names>
                    </name>
                    <name>
                      <surname>de Roos</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>de Craen</surname>
                      <given-names>AJ</given-names>
                    </name>
                    <name>
                      <surname>Westendorp</surname>
                      <given-names>RG</given-names>
                    </name>
                    <name>
                      <surname>Blauw</surname>
                      <given-names>GJ</given-names>
                    </name>
                    <name>
                      <surname>Jukema</surname>
                      <given-names>JW</given-names>
                    </name>
                    <name>
                      <surname>Bollen</surname>
                      <given-names>EL</given-names>
                    </name>
                    <name>
                      <surname>Middelkoop</surname>
                      <given-names>HA</given-names>
                    </name>
                    <name>
                      <surname>van Buchem</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>van der Grond</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up</article-title>
                  <source>Neurology</source>
                  <year>2010</year>
                  <volume>75</volume>
                  <issue>11</issue>
                  <fpage>997</fpage>
                  <lpage>1002</lpage>
                  <pub-id pub-id-type="doi">10.1212/WNL.0b013e3181f25f06</pub-id>
                  <?supplied-pmid 20837967?>
                  <pub-id pub-id-type="pmid">20837967</pub-id>
                </element-citation>
              </ref>
              <ref id="CR10">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Launer</surname>
                      <given-names>LJ</given-names>
                    </name>
                    <name>
                      <surname>Miller</surname>
                      <given-names>ME</given-names>
                    </name>
                    <name>
                      <surname>Williamson</surname>
                      <given-names>JD</given-names>
                    </name>
                    <name>
                      <surname>Lazar</surname>
                      <given-names>RM</given-names>
                    </name>
                    <name>
                      <surname>Gerstein</surname>
                      <given-names>HC</given-names>
                    </name>
                    <name>
                      <surname>Murray</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Sullivan</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Horowitz</surname>
                      <given-names>KR</given-names>
                    </name>
                    <name>
                      <surname>Ding</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Marcovina</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy</article-title>
                  <source>Lancet Neurol</source>
                  <year>2011</year>
                  <volume>10</volume>
                  <issue>11</issue>
                  <fpage>969</fpage>
                  <lpage>977</lpage>
                  <pub-id pub-id-type="doi">10.1016/S1474-4422(11)70188-0</pub-id>
                  <?supplied-pmid 21958949?>
                  <pub-id pub-id-type="pmid">21958949</pub-id>
                </element-citation>
              </ref>
              <ref id="CR11">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Christman</surname>
                      <given-names>AL</given-names>
                    </name>
                    <name>
                      <surname>Matsushita</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Gottesman</surname>
                      <given-names>RF</given-names>
                    </name>
                    <name>
                      <surname>Mosley</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Alonso</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Coresh</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Hill-Briggs</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Sharrett</surname>
                      <given-names>AR</given-names>
                    </name>
                    <name>
                      <surname>Selvin</surname>
                      <given-names>E</given-names>
                    </name>
                  </person-group>
                  <article-title>Glycated haemoglobin and cognitive decline: the Atherosclerosis Risk in Communities (ARIC) study</article-title>
                  <source>Diabetologia</source>
                  <year>2011</year>
                  <volume>54</volume>
                  <issue>7</issue>
                  <fpage>1645</fpage>
                  <lpage>1652</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00125-011-2095-7</pub-id>
                  <?supplied-pmid 21360189?>
                  <pub-id pub-id-type="pmid">21360189</pub-id>
                </element-citation>
              </ref>
              <ref id="CR12">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Christman</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Matsushita</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Gottesman</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Mosley</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Alonso</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Coresh</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Hill-Briggs</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Sharrett</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Selvin</surname>
                      <given-names>E</given-names>
                    </name>
                  </person-group>
                  <article-title>Glycated haemoglobin and cognitive decline: the Atherosclerosis Risk in Communities (ARIC) study</article-title>
                  <source>Diabetologia</source>
                  <year>2011</year>
                  <volume>54</volume>
                  <issue>7</issue>
                  <fpage>1645</fpage>
                  <lpage>1652</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00125-011-2095-7</pub-id>
                  <?supplied-pmid 21360189?>
                  <pub-id pub-id-type="pmid">21360189</pub-id>
                </element-citation>
              </ref>
              <ref id="CR13">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <collab>Action to Control Cardiovascular Risk in Diabetes Study G</collab>
                    <name>
                      <surname>Gerstein</surname>
                      <given-names>HC</given-names>
                    </name>
                    <name>
                      <surname>Miller</surname>
                      <given-names>ME</given-names>
                    </name>
                    <name>
                      <surname>Byington</surname>
                      <given-names>RP</given-names>
                    </name>
                    <name>
                      <surname>Goff</surname>
                      <given-names>DC</given-names>
                      <suffix>Jr</suffix>
                    </name>
                    <name>
                      <surname>Bigger</surname>
                      <given-names>JT</given-names>
                    </name>
                    <name>
                      <surname>Buse</surname>
                      <given-names>JB</given-names>
                    </name>
                    <name>
                      <surname>Cushman</surname>
                      <given-names>WC</given-names>
                    </name>
                    <name>
                      <surname>Genuth</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Ismail-Beigi</surname>
                      <given-names>F</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Effects of intensive glucose lowering in type 2 diabetes</article-title>
                  <source>N Engl J Med</source>
                  <year>2008</year>
                  <volume>358</volume>
                  <issue>24</issue>
                  <fpage>2545</fpage>
                  <lpage>2559</lpage>
                  <pub-id pub-id-type="doi">10.1056/NEJMoa0802743</pub-id>
                  <pub-id pub-id-type="pmid">18539917</pub-id>
                </element-citation>
              </ref>
              <ref id="CR14">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Punthakee</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Miller</surname>
                      <given-names>ME</given-names>
                    </name>
                    <name>
                      <surname>Launer</surname>
                      <given-names>LJ</given-names>
                    </name>
                    <name>
                      <surname>Williamson</surname>
                      <given-names>JD</given-names>
                    </name>
                    <name>
                      <surname>Lazar</surname>
                      <given-names>RM</given-names>
                    </name>
                    <name>
                      <surname>Cukierman-Yaffee</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Seaquist</surname>
                      <given-names>ER</given-names>
                    </name>
                    <name>
                      <surname>Ismail-Beigi</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Sullivan</surname>
                      <given-names>MD</given-names>
                    </name>
                    <name>
                      <surname>Lovato</surname>
                      <given-names>LC</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial</article-title>
                  <source>Diabetes Care</source>
                  <year>2012</year>
                  <volume>35</volume>
                  <issue>4</issue>
                  <fpage>787</fpage>
                  <lpage>793</lpage>
                  <pub-id pub-id-type="doi">10.2337/dc11-1855</pub-id>
                  <?supplied-pmid 22374637?>
                  <pub-id pub-id-type="pmid">22374637</pub-id>
                </element-citation>
              </ref>
              <ref id="CR15">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Murray</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Hsu</surname>
                      <given-names>FC</given-names>
                    </name>
                    <name>
                      <surname>Williamson</surname>
                      <given-names>JD</given-names>
                    </name>
                    <name>
                      <surname>Bryan</surname>
                      <given-names>RN</given-names>
                    </name>
                    <name>
                      <surname>Gerstein</surname>
                      <given-names>HC</given-names>
                    </name>
                    <name>
                      <surname>Sullivan</surname>
                      <given-names>MD</given-names>
                    </name>
                    <name>
                      <surname>Miller</surname>
                      <given-names>ME</given-names>
                    </name>
                    <name>
                      <surname>Leng</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Lovato</surname>
                      <given-names>LL</given-names>
                    </name>
                    <name>
                      <surname>Launer</surname>
                      <given-names>LJ</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>ACCORDION MIND: results of the observational extension of the ACCORD MIND randomised trial</article-title>
                  <source>Diabetologia</source>
                  <year>2017</year>
                  <volume>60</volume>
                  <issue>1</issue>
                  <fpage>69</fpage>
                  <lpage>80</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00125-016-4118-x</pub-id>
                  <?supplied-pmid 27766347?>
                  <pub-id pub-id-type="pmid">27766347</pub-id>
                </element-citation>
              </ref>
              <ref id="CR16">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Palmieri</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Bella</surname>
                      <given-names>JN</given-names>
                    </name>
                    <name>
                      <surname>Arnett</surname>
                      <given-names>DK</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>JE</given-names>
                    </name>
                    <name>
                      <surname>Oberman</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Schuck</surname>
                      <given-names>MY</given-names>
                    </name>
                    <name>
                      <surname>Kitzman</surname>
                      <given-names>DW</given-names>
                    </name>
                    <name>
                      <surname>Hopkins</surname>
                      <given-names>PN</given-names>
                    </name>
                    <name>
                      <surname>Morgan</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Rao</surname>
                      <given-names>DC</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study</article-title>
                  <source>Circulation</source>
                  <year>2001</year>
                  <volume>103</volume>
                  <issue>1</issue>
                  <fpage>102</fpage>
                  <lpage>107</lpage>
                  <pub-id pub-id-type="doi">10.1161/01.CIR.103.1.102</pub-id>
                  <?supplied-pmid 11136693?>
                  <pub-id pub-id-type="pmid">11136693</pub-id>
                </element-citation>
              </ref>
              <ref id="CR17">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Boonman-de Winter</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Rutten</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Cramer</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Landman</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Liem</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Rutten</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Hoes</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes</article-title>
                  <source>Diabetologia</source>
                  <year>2012</year>
                  <volume>55</volume>
                  <issue>8</issue>
                  <fpage>2154</fpage>
                  <lpage>2162</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00125-012-2579-0</pub-id>
                  <?supplied-pmid 22618812?>
                  <pub-id pub-id-type="pmid">22618812</pub-id>
                </element-citation>
              </ref>
              <ref id="CR18">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Srivastava</surname>
                      <given-names>PM</given-names>
                    </name>
                    <name>
                      <surname>Calafiore</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Macisaac</surname>
                      <given-names>RJ</given-names>
                    </name>
                    <name>
                      <surname>Patel</surname>
                      <given-names>SK</given-names>
                    </name>
                    <name>
                      <surname>Thomas</surname>
                      <given-names>MC</given-names>
                    </name>
                    <name>
                      <surname>Jerums</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Burrell</surname>
                      <given-names>LM</given-names>
                    </name>
                  </person-group>
                  <article-title>Prevalence and predictors of cardiac hypertrophy and dysfunction in patients with Type 2 diabetes</article-title>
                  <source>Clin Sci</source>
                  <year>2008</year>
                  <volume>114</volume>
                  <issue>4</issue>
                  <fpage>313</fpage>
                  <lpage>320</lpage>
                  <pub-id pub-id-type="doi">10.1042/CS20070261</pub-id>
                  <?supplied-pmid 17916064?>
                  <pub-id pub-id-type="pmid">17916064</pub-id>
                </element-citation>
              </ref>
              <ref id="CR19">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cuspidi</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Sala</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Negri</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Mancia</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Morganti</surname>
                      <given-names>A</given-names>
                    </name>
                    <collab>Italian Society of H</collab>
                  </person-group>
                  <article-title>Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies</article-title>
                  <source>J Hum Hypertens</source>
                  <year>2012</year>
                  <volume>26</volume>
                  <issue>6</issue>
                  <fpage>343</fpage>
                  <lpage>349</lpage>
                  <pub-id pub-id-type="doi">10.1038/jhh.2011.104</pub-id>
                  <?supplied-pmid 22113443?>
                  <pub-id pub-id-type="pmid">22113443</pub-id>
                </element-citation>
              </ref>
              <ref id="CR20">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bikkina</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Levy</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Evans</surname>
                      <given-names>JC</given-names>
                    </name>
                    <name>
                      <surname>Larson</surname>
                      <given-names>MG</given-names>
                    </name>
                    <name>
                      <surname>Benjamin</surname>
                      <given-names>EJ</given-names>
                    </name>
                    <name>
                      <surname>Wolf</surname>
                      <given-names>PA</given-names>
                    </name>
                    <name>
                      <surname>Castelli</surname>
                      <given-names>WP</given-names>
                    </name>
                  </person-group>
                  <article-title>Left ventricular mass and risk of stroke in an elderly cohort. The Framingham Heart Study</article-title>
                  <source>JAMA</source>
                  <year>1994</year>
                  <volume>272</volume>
                  <issue>1</issue>
                  <fpage>33</fpage>
                  <lpage>36</lpage>
                  <pub-id pub-id-type="doi">10.1001/jama.1994.03520010045030</pub-id>
                  <?supplied-pmid 8007076?>
                  <pub-id pub-id-type="pmid">8007076</pub-id>
                </element-citation>
              </ref>
              <ref id="CR21">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bombelli</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Facchetti</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Carugo</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Madotto</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Arenare</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Quarti-Trevano</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Capra</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Giannattasio</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Dell’Oro</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Grassi</surname>
                      <given-names>G</given-names>
                    </name>
                  </person-group>
                  <article-title>Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values</article-title>
                  <source>J Hypertens</source>
                  <year>2009</year>
                  <volume>27</volume>
                  <issue>12</issue>
                  <fpage>2458</fpage>
                  <lpage>2464</lpage>
                  <pub-id pub-id-type="doi">10.1097/HJH.0b013e328330b845</pub-id>
                  <?supplied-pmid 19654559?>
                  <pub-id pub-id-type="pmid">19654559</pub-id>
                </element-citation>
              </ref>
              <ref id="CR22">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Filley</surname>
                      <given-names>CM</given-names>
                    </name>
                    <name>
                      <surname>Brodtmann</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Lacunes and cognitive decline: little things matter</article-title>
                  <source>Neurology</source>
                  <year>2011</year>
                  <volume>76</volume>
                  <issue>22</issue>
                  <fpage>1856</fpage>
                  <lpage>1857</lpage>
                  <pub-id pub-id-type="doi">10.1212/WNL.0b013e31821d7563</pub-id>
                  <?supplied-pmid 21543732?>
                  <pub-id pub-id-type="pmid">21543732</pub-id>
                </element-citation>
              </ref>
              <ref id="CR23">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Eggermont</surname>
                      <given-names>LH</given-names>
                    </name>
                    <name>
                      <surname>de Boer</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Muller</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Jaschke</surname>
                      <given-names>AC</given-names>
                    </name>
                    <name>
                      <surname>Kamp</surname>
                      <given-names>O</given-names>
                    </name>
                    <name>
                      <surname>Scherder</surname>
                      <given-names>EJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Cardiac disease and cognitive impairment: a systematic review</article-title>
                  <source>Heart</source>
                  <year>2012</year>
                  <volume>98</volume>
                  <issue>18</issue>
                  <fpage>1334</fpage>
                  <lpage>1340</lpage>
                  <pub-id pub-id-type="doi">10.1136/heartjnl-2012-301682</pub-id>
                  <?supplied-pmid 22689718?>
                  <pub-id pub-id-type="pmid">22689718</pub-id>
                </element-citation>
              </ref>
              <ref id="CR24">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Vogels</surname>
                      <given-names>RL</given-names>
                    </name>
                    <name>
                      <surname>Oosterman</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>van Harten</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Gouw</surname>
                      <given-names>AA</given-names>
                    </name>
                    <name>
                      <surname>Schroeder-Tanka</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Scheltens</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>van der Flier</surname>
                      <given-names>WM</given-names>
                    </name>
                    <name>
                      <surname>Weinstein</surname>
                      <given-names>HC</given-names>
                    </name>
                  </person-group>
                  <article-title>Neuroimaging and correlates of cognitive function among patients with heart failure</article-title>
                  <source>Dement Geriatr Cogn Disord</source>
                  <year>2007</year>
                  <volume>24</volume>
                  <issue>6</issue>
                  <fpage>418</fpage>
                  <lpage>423</lpage>
                  <pub-id pub-id-type="doi">10.1159/000109811</pub-id>
                  <?supplied-pmid 17938570?>
                  <pub-id pub-id-type="pmid">17938570</pub-id>
                </element-citation>
              </ref>
              <ref id="CR25">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Vogels</surname>
                      <given-names>RL</given-names>
                    </name>
                    <name>
                      <surname>Scheltens</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Schroeder-Tanka</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Weinstein</surname>
                      <given-names>HC</given-names>
                    </name>
                  </person-group>
                  <article-title>Cognitive impairment in heart failure: a systematic review of the literature</article-title>
                  <source>Eur J Heart Fail</source>
                  <year>2007</year>
                  <volume>9</volume>
                  <issue>5</issue>
                  <fpage>440</fpage>
                  <lpage>449</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.ejheart.2006.11.001</pub-id>
                  <?supplied-pmid 17174152?>
                  <pub-id pub-id-type="pmid">17174152</pub-id>
                </element-citation>
              </ref>
              <ref id="CR26">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Vogels</surname>
                      <given-names>RL</given-names>
                    </name>
                    <name>
                      <surname>van der Flier</surname>
                      <given-names>WM</given-names>
                    </name>
                    <name>
                      <surname>van Harten</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Gouw</surname>
                      <given-names>AA</given-names>
                    </name>
                    <name>
                      <surname>Scheltens</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Schroeder-Tanka</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Weinstein</surname>
                      <given-names>HC</given-names>
                    </name>
                  </person-group>
                  <article-title>Brain magnetic resonance imaging abnormalities in patients with heart failure</article-title>
                  <source>Eur J Heart Fail</source>
                  <year>2007</year>
                  <volume>9</volume>
                  <issue>10</issue>
                  <fpage>1003</fpage>
                  <lpage>1009</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.ejheart.2007.07.006</pub-id>
                  <?supplied-pmid 17719270?>
                  <pub-id pub-id-type="pmid">17719270</pub-id>
                </element-citation>
              </ref>
              <ref id="CR27">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wendell</surname>
                      <given-names>CR</given-names>
                    </name>
                    <name>
                      <surname>Zonderman</surname>
                      <given-names>AB</given-names>
                    </name>
                    <name>
                      <surname>Metter</surname>
                      <given-names>EJ</given-names>
                    </name>
                    <name>
                      <surname>Najjar</surname>
                      <given-names>SS</given-names>
                    </name>
                    <name>
                      <surname>Waldstein</surname>
                      <given-names>SR</given-names>
                    </name>
                  </person-group>
                  <article-title>Carotid intimal medial thickness predicts cognitive decline among adults without clinical vascular disease</article-title>
                  <source>Stroke</source>
                  <year>2009</year>
                  <volume>40</volume>
                  <issue>10</issue>
                  <fpage>3180</fpage>
                  <lpage>3185</lpage>
                  <pub-id pub-id-type="doi">10.1161/STROKEAHA.109.557280</pub-id>
                  <?supplied-pmid 19644063?>
                  <pub-id pub-id-type="pmid">19644063</pub-id>
                </element-citation>
              </ref>
              <ref id="CR28">
                <label>28.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Scuteri</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Coluccia</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Castello</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Nevola</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Brancati</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Volpe</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Left ventricular mass increase is associated with cognitive decline and dementia in the elderly independently of blood pressure</article-title>
                  <source>Eur Heart J</source>
                  <year>2009</year>
                  <volume>30</volume>
                  <issue>12</issue>
                  <fpage>1525</fpage>
                  <lpage>1529</lpage>
                  <pub-id pub-id-type="doi">10.1093/eurheartj/ehp133</pub-id>
                  <?supplied-pmid 19406864?>
                  <pub-id pub-id-type="pmid">19406864</pub-id>
                </element-citation>
              </ref>
              <ref id="CR29">
                <label>29.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Elias</surname>
                      <given-names>MF</given-names>
                    </name>
                    <name>
                      <surname>Sullivan</surname>
                      <given-names>LM</given-names>
                    </name>
                    <name>
                      <surname>Elias</surname>
                      <given-names>PK</given-names>
                    </name>
                    <name>
                      <surname>D’Agostino</surname>
                      <given-names>RB</given-names>
                      <suffix>Sr</suffix>
                    </name>
                    <name>
                      <surname>Wolf</surname>
                      <given-names>PA</given-names>
                    </name>
                    <name>
                      <surname>Seshadri</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Au</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Benjamin</surname>
                      <given-names>EJ</given-names>
                    </name>
                    <name>
                      <surname>Vasan</surname>
                      <given-names>RS</given-names>
                    </name>
                  </person-group>
                  <article-title>Left ventricular mass, blood pressure, and lowered cognitive performance in the Framingham offspring</article-title>
                  <source>Hypertension</source>
                  <year>2007</year>
                  <volume>49</volume>
                  <issue>3</issue>
                  <fpage>439</fpage>
                  <lpage>445</lpage>
                  <pub-id pub-id-type="doi">10.1161/01.HYP.0000256361.68158.24</pub-id>
                  <?supplied-pmid 17224472?>
                  <pub-id pub-id-type="pmid">17224472</pub-id>
                </element-citation>
              </ref>
              <ref id="CR30">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jefferson</surname>
                      <given-names>AL</given-names>
                    </name>
                    <name>
                      <surname>Himali</surname>
                      <given-names>JJ</given-names>
                    </name>
                    <name>
                      <surname>Au</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Seshadri</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Decarli</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>O’Donnell</surname>
                      <given-names>CJ</given-names>
                    </name>
                    <name>
                      <surname>Wolf</surname>
                      <given-names>PA</given-names>
                    </name>
                    <name>
                      <surname>Manning</surname>
                      <given-names>WJ</given-names>
                    </name>
                    <name>
                      <surname>Beiser</surname>
                      <given-names>AS</given-names>
                    </name>
                    <name>
                      <surname>Benjamin</surname>
                      <given-names>EJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Relation of left ventricular ejection fraction to cognitive aging (from the Framingham Heart Study)</article-title>
                  <source>Am J Cardiol</source>
                  <year>2011</year>
                  <volume>108</volume>
                  <issue>9</issue>
                  <fpage>1346</fpage>
                  <lpage>1351</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.amjcard.2011.06.056</pub-id>
                  <?supplied-pmid 21880293?>
                  <pub-id pub-id-type="pmid">21880293</pub-id>
                </element-citation>
              </ref>
              <ref id="CR31">
                <label>31.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lang</surname>
                      <given-names>RM</given-names>
                    </name>
                    <name>
                      <surname>Bierig</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Devereux</surname>
                      <given-names>RB</given-names>
                    </name>
                    <name>
                      <surname>Flachskampf</surname>
                      <given-names>FA</given-names>
                    </name>
                    <name>
                      <surname>Foster</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Pellikka</surname>
                      <given-names>PA</given-names>
                    </name>
                    <name>
                      <surname>Picard</surname>
                      <given-names>MH</given-names>
                    </name>
                    <name>
                      <surname>Roman</surname>
                      <given-names>MJ</given-names>
                    </name>
                    <name>
                      <surname>Seward</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Shanewise</surname>
                      <given-names>JS</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology</article-title>
                  <source>JAm Soc Echocardiogr</source>
                  <year>2005</year>
                  <volume>18</volume>
                  <issue>12</issue>
                  <fpage>1440</fpage>
                  <lpage>1463</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.echo.2005.10.005</pub-id>
                  <pub-id pub-id-type="pmid">16376782</pub-id>
                </element-citation>
              </ref>
              <ref id="CR32">
                <label>32.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Moneta</surname>
                      <given-names>GL</given-names>
                    </name>
                    <name>
                      <surname>Edwards</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Chitwood</surname>
                      <given-names>RW</given-names>
                    </name>
                    <name>
                      <surname>Taylor</surname>
                      <given-names>LM</given-names>
                      <suffix>Jr</suffix>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>RW</given-names>
                    </name>
                    <name>
                      <surname>Cummings</surname>
                      <given-names>CA</given-names>
                    </name>
                    <name>
                      <surname>Porter</surname>
                      <given-names>JM</given-names>
                    </name>
                  </person-group>
                  <article-title>Correlation of North American Symptomatic Carotid Endarterectomy Trial (NASCET) angiographic definition of 70% to 99% internal carotid artery stenosis with duplex scanning</article-title>
                  <source>J Vasc Surg</source>
                  <year>1993</year>
                  <volume>17</volume>
                  <issue>1</issue>
                  <fpage>152</fpage>
                  <lpage>157</lpage>
                  <pub-id pub-id-type="doi">10.1016/0741-5214(93)90019-I</pub-id>
                  <?supplied-pmid 8421332?>
                  <pub-id pub-id-type="pmid">8421332</pub-id>
                </element-citation>
              </ref>
              <ref id="CR33">
                <label>33.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fischl</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Dale</surname>
                      <given-names>AM</given-names>
                    </name>
                  </person-group>
                  <article-title>Measuring the thickness of the human cerebral cortex from magnetic resonance images</article-title>
                  <source>Proc Natl Acad Sci U S A</source>
                  <year>2000</year>
                  <volume>97</volume>
                  <issue>20</issue>
                  <fpage>11050</fpage>
                  <lpage>11055</lpage>
                  <pub-id pub-id-type="doi">10.1073/pnas.200033797</pub-id>
                  <?supplied-pmid 10984517?>
                  <pub-id pub-id-type="pmid">10984517</pub-id>
                </element-citation>
              </ref>
              <ref id="CR34">
                <label>34.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pardoe</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Pell</surname>
                      <given-names>GS</given-names>
                    </name>
                    <name>
                      <surname>Abbott</surname>
                      <given-names>DF</given-names>
                    </name>
                    <name>
                      <surname>Berg</surname>
                      <given-names>AT</given-names>
                    </name>
                    <name>
                      <surname>Jackson</surname>
                      <given-names>GD</given-names>
                    </name>
                  </person-group>
                  <article-title>Multi-site voxel-based morphometry: methods and a feasibility demonstration with childhood absence epilepsy</article-title>
                  <source>Neuroimage</source>
                  <year>2008</year>
                  <volume>42</volume>
                  <issue>2</issue>
                  <fpage>611</fpage>
                  <lpage>616</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.neuroimage.2008.05.007</pub-id>
                  <?supplied-pmid 18585930?>
                  <pub-id pub-id-type="pmid">18585930</pub-id>
                </element-citation>
              </ref>
              <ref id="CR35">
                <label>35.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pardoe</surname>
                      <given-names>HR</given-names>
                    </name>
                    <name>
                      <surname>Pell</surname>
                      <given-names>GS</given-names>
                    </name>
                    <name>
                      <surname>Abbott</surname>
                      <given-names>DF</given-names>
                    </name>
                    <name>
                      <surname>Jackson</surname>
                      <given-names>GD</given-names>
                    </name>
                  </person-group>
                  <article-title>Hippocampal volume assessment in temporal lobe epilepsy: How good is automated segmentation?</article-title>
                  <source>Epilepsia</source>
                  <year>2009</year>
                  <volume>50</volume>
                  <issue>12</issue>
                  <fpage>2586</fpage>
                  <lpage>2592</lpage>
                  <pub-id pub-id-type="doi">10.1111/j.1528-1167.2009.02243.x</pub-id>
                  <?supplied-pmid 19682030?>
                  <pub-id pub-id-type="pmid">19682030</pub-id>
                </element-citation>
              </ref>
              <ref id="CR36">
                <label>36.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Brodtmann</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Werden</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Pardoe</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>Q</given-names>
                    </name>
                    <name>
                      <surname>Jackson</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Donnan</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Cowie</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Bradshaw</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Darby</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Cumming</surname>
                      <given-names>T</given-names>
                    </name>
                  </person-group>
                  <article-title>Charting cognitive and volumetric trajectories after stroke: protocol for the Cognition And Neocortical Volume After Stroke (CANVAS) study</article-title>
                  <source>Int J Stroke</source>
                  <year>2014</year>
                  <volume>9</volume>
                  <issue>6</issue>
                  <fpage>824</fpage>
                  <lpage>828</lpage>
                  <pub-id pub-id-type="doi">10.1111/ijs.12301</pub-id>
                  <?supplied-pmid 24894387?>
                  <pub-id pub-id-type="pmid">24894387</pub-id>
                </element-citation>
              </ref>
              <ref id="CR37">
                <label>37.</label>
                <mixed-citation publication-type="other">American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: Am Psychiatr Assoc; 2013.</mixed-citation>
              </ref>
              <ref id="CR38">
                <label>38.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kim</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Tanabe</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Yokoyama</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Zempo</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Kuno</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>Objectively measured light-intensity lifestyle activity and sedentary time are independently associated with metabolic syndrome: a cross-sectional study of Japanese adults</article-title>
                  <source>Int J Behav Nutr Phys Act</source>
                  <year>2013</year>
                  <volume>10</volume>
                  <fpage>30</fpage>
                  <pub-id pub-id-type="doi">10.1186/1479-5868-10-30</pub-id>
                  <?supplied-pmid 23452372?>
                  <pub-id pub-id-type="pmid">23452372</pub-id>
                </element-citation>
              </ref>
              <ref id="CR39">
                <label>39.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>St-Onge</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Mignault</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Allison</surname>
                      <given-names>DB</given-names>
                    </name>
                    <name>
                      <surname>Rabasa-Lhoret</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>Evaluation of a portable device to measure daily energy expenditure in free-living adults</article-title>
                  <source>Am J Clin Nutr</source>
                  <year>2007</year>
                  <volume>85</volume>
                  <issue>3</issue>
                  <fpage>742</fpage>
                  <lpage>749</lpage>
                  <?supplied-pmid 17344495?>
                  <pub-id pub-id-type="pmid">17344495</pub-id>
                </element-citation>
              </ref>
              <ref id="CR40">
                <label>40.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chen</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Langbaum</surname>
                      <given-names>JB</given-names>
                    </name>
                    <name>
                      <surname>Fleisher</surname>
                      <given-names>AS</given-names>
                    </name>
                    <name>
                      <surname>Ayutyanont</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Reschke</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>X</given-names>
                    </name>
                    <name>
                      <surname>Bandy</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Alexander</surname>
                      <given-names>GE</given-names>
                    </name>
                    <name>
                      <surname>Thompson</surname>
                      <given-names>PM</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Twelve-month metabolic declines in probable Alzheimer’s disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer’s Disease Neuroimaging Initiative</article-title>
                  <source>Neuroimage</source>
                  <year>2010</year>
                  <volume>51</volume>
                  <issue>2</issue>
                  <fpage>654</fpage>
                  <lpage>664</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.neuroimage.2010.02.064</pub-id>
                  <?supplied-pmid 20202480?>
                  <pub-id pub-id-type="pmid">20202480</pub-id>
                </element-citation>
              </ref>
              <ref id="CR41">
                <label>41.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hua</surname>
                      <given-names>X</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Hibar</surname>
                      <given-names>DP</given-names>
                    </name>
                    <name>
                      <surname>Yanovsky</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Leow</surname>
                      <given-names>AD</given-names>
                    </name>
                    <name>
                      <surname>Toga</surname>
                      <given-names>AW</given-names>
                    </name>
                    <name>
                      <surname>Jack</surname>
                      <given-names>CR</given-names>
                      <suffix>Jr</suffix>
                    </name>
                    <name>
                      <surname>Bernstein</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Reiman</surname>
                      <given-names>EM</given-names>
                    </name>
                    <name>
                      <surname>Harvey</surname>
                      <given-names>DJ</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Mapping Alzheimer’s disease progression in 1309 MRI scans: power estimates for different inter-scan intervals</article-title>
                  <source>Neuroimage</source>
                  <year>2010</year>
                  <volume>51</volume>
                  <issue>1</issue>
                  <fpage>63</fpage>
                  <lpage>75</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.neuroimage.2010.01.104</pub-id>
                  <?supplied-pmid 20139010?>
                  <pub-id pub-id-type="pmid">20139010</pub-id>
                </element-citation>
              </ref>
              <ref id="CR42">
                <label>42.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Leow</surname>
                      <given-names>AD</given-names>
                    </name>
                    <name>
                      <surname>Yanovsky</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Parikshak</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Hua</surname>
                      <given-names>X</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Toga</surname>
                      <given-names>AW</given-names>
                    </name>
                    <name>
                      <surname>Jack</surname>
                      <given-names>CR</given-names>
                      <suffix>Jr</suffix>
                    </name>
                    <name>
                      <surname>Bernstein</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Britson</surname>
                      <given-names>PJ</given-names>
                    </name>
                    <name>
                      <surname>Gunter</surname>
                      <given-names>JL</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Alzheimer’s disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition</article-title>
                  <source>Neuroimage</source>
                  <year>2009</year>
                  <volume>45</volume>
                  <issue>3</issue>
                  <fpage>645</fpage>
                  <lpage>655</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.neuroimage.2009.01.004</pub-id>
                  <?supplied-pmid 19280686?>
                  <pub-id pub-id-type="pmid">19280686</pub-id>
                </element-citation>
              </ref>
              <ref id="CR43">
                <label>43.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Brodtmann</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Puce</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Darby</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Donnan</surname>
                      <given-names>G</given-names>
                    </name>
                  </person-group>
                  <article-title>Regional fMRI brain activation does correlate with global brain volume</article-title>
                  <source>Brain Res</source>
                  <year>2009</year>
                  <volume>1259</volume>
                  <fpage>17</fpage>
                  <lpage>25</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.brainres.2008.12.044</pub-id>
                  <?supplied-pmid 19133239?>
                  <pub-id pub-id-type="pmid">19133239</pub-id>
                </element-citation>
              </ref>
              <ref id="CR44">
                <label>44.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nitkunan</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Lanfranconi</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Charlton</surname>
                      <given-names>RA</given-names>
                    </name>
                    <name>
                      <surname>Barrick</surname>
                      <given-names>TR</given-names>
                    </name>
                    <name>
                      <surname>Markus</surname>
                      <given-names>HS</given-names>
                    </name>
                  </person-group>
                  <article-title>Brain atrophy and cerebral small vessel disease: a prospective follow-up study</article-title>
                  <source>Stroke</source>
                  <year>2011</year>
                  <volume>42</volume>
                  <issue>1</issue>
                  <fpage>133</fpage>
                  <lpage>138</lpage>
                  <pub-id pub-id-type="doi">10.1161/STROKEAHA.110.594267</pub-id>
                  <?supplied-pmid 21148440?>
                  <pub-id pub-id-type="pmid">21148440</pub-id>
                </element-citation>
              </ref>
              <ref id="CR45">
                <label>45.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nasreddine</surname>
                      <given-names>ZS</given-names>
                    </name>
                    <name>
                      <surname>Phillips</surname>
                      <given-names>NA</given-names>
                    </name>
                    <name>
                      <surname>Bédirian</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Charbonneau</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Whitehead</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Collin</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Cummings</surname>
                      <given-names>JL</given-names>
                    </name>
                    <name>
                      <surname>Chertkow</surname>
                      <given-names>H</given-names>
                    </name>
                  </person-group>
                  <article-title>The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment</article-title>
                  <source>J Am Geriatr Soc</source>
                  <year>2005</year>
                  <volume>53</volume>
                  <issue>4</issue>
                  <fpage>695</fpage>
                  <lpage>699</lpage>
                  <pub-id pub-id-type="doi">10.1111/j.1532-5415.2005.53221.x</pub-id>
                  <?supplied-pmid 15817019?>
                  <pub-id pub-id-type="pmid">15817019</pub-id>
                </element-citation>
              </ref>
              <ref id="CR46">
                <label>46.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Morris</surname>
                      <given-names>JC</given-names>
                    </name>
                  </person-group>
                  <article-title>The Clinical Dementia Rating (CDR): current version and scoring rules</article-title>
                  <source>Neurology</source>
                  <year>1993</year>
                  <volume>43</volume>
                  <issue>11</issue>
                  <fpage>2412</fpage>
                  <lpage>2414</lpage>
                  <pub-id pub-id-type="doi">10.1212/WNL.43.11.2412-a</pub-id>
                  <?supplied-pmid 8232972?>
                  <pub-id pub-id-type="pmid">8232972</pub-id>
                </element-citation>
              </ref>
              <ref id="CR47">
                <label>47.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nelson</surname>
                      <given-names>HE</given-names>
                    </name>
                    <name>
                      <surname>Willison</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <source>National Adult Reading Test (NART): Nfer-Nelson Windsor</source>
                  <year>1991</year>
                </element-citation>
              </ref>
              <ref id="CR48">
                <label>48.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tombaugh</surname>
                      <given-names>TN</given-names>
                    </name>
                  </person-group>
                  <article-title>Trail Making Test A and B: normative data stratified by age and education</article-title>
                  <source>Arch Clin Neuropsychol</source>
                  <year>2004</year>
                  <volume>19</volume>
                  <issue>2</issue>
                  <fpage>203</fpage>
                  <lpage>214</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0887-6177(03)00039-8</pub-id>
                  <?supplied-pmid 15010086?>
                  <pub-id pub-id-type="pmid">15010086</pub-id>
                </element-citation>
              </ref>
              <ref id="CR49">
                <label>49.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wechsler</surname>
                      <given-names>D</given-names>
                    </name>
                  </person-group>
                  <source>Wechsler Adult Intelligence Scale–Fourth Edition (WAIS–IV)</source>
                  <year>2014</year>
                </element-citation>
              </ref>
              <ref id="CR50">
                <label>50.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Maruff</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Lim</surname>
                      <given-names>YY</given-names>
                    </name>
                    <name>
                      <surname>Darby</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Ellis</surname>
                      <given-names>KA</given-names>
                    </name>
                    <name>
                      <surname>Pietrzak</surname>
                      <given-names>RH</given-names>
                    </name>
                    <name>
                      <surname>Snyder</surname>
                      <given-names>PJ</given-names>
                    </name>
                    <name>
                      <surname>Bush</surname>
                      <given-names>AI</given-names>
                    </name>
                    <name>
                      <surname>Szoeke</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Schembri</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Ames</surname>
                      <given-names>D</given-names>
                    </name>
                  </person-group>
                  <article-title>Clinical utility of the cogstate brief battery in identifying cognitive impairment in mild cognitive impairment and Alzheimer’s disease</article-title>
                  <source>BMC Pharmacol Toxicol</source>
                  <year>2013</year>
                  <volume>1</volume>
                  <issue>30</issue>
                  <fpage>1</fpage>
                  <lpage>11</lpage>
                </element-citation>
              </ref>
              <ref id="CR51">
                <label>51.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Meyers</surname>
                      <given-names>JE</given-names>
                    </name>
                    <name>
                      <surname>Meyers</surname>
                      <given-names>KR</given-names>
                    </name>
                  </person-group>
                  <article-title>Rey complex figure test under four different administration procedures</article-title>
                  <source>Clin Neuropsychol</source>
                  <year>1995</year>
                  <volume>9</volume>
                  <issue>1</issue>
                  <fpage>63</fpage>
                  <lpage>67</lpage>
                  <pub-id pub-id-type="doi">10.1080/13854049508402059</pub-id>
                </element-citation>
              </ref>
              <ref id="CR52">
                <label>52.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Royall</surname>
                      <given-names>DR</given-names>
                    </name>
                    <name>
                      <surname>Cordes</surname>
                      <given-names>JA</given-names>
                    </name>
                    <name>
                      <surname>Polk</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>CLOX: an executive clock drawing task</article-title>
                  <source>J Neurol Neurosurg Psychiatry</source>
                  <year>1998</year>
                  <volume>64</volume>
                  <issue>5</issue>
                  <fpage>588</fpage>
                  <lpage>594</lpage>
                  <pub-id pub-id-type="doi">10.1136/jnnp.64.5.588</pub-id>
                  <?supplied-pmid 9598672?>
                  <pub-id pub-id-type="pmid">9598672</pub-id>
                </element-citation>
              </ref>
              <ref id="CR53">
                <label>53.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tombaugh</surname>
                      <given-names>TN</given-names>
                    </name>
                    <name>
                      <surname>Kozak</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Rees</surname>
                      <given-names>L</given-names>
                    </name>
                  </person-group>
                  <article-title>Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming</article-title>
                  <source>Arch Clin Neuropsychol</source>
                  <year>1999</year>
                  <volume>14</volume>
                  <issue>2</issue>
                  <fpage>167</fpage>
                  <lpage>177</lpage>
                  <?supplied-pmid 14590600?>
                  <pub-id pub-id-type="pmid">14590600</pub-id>
                </element-citation>
              </ref>
              <ref id="CR54">
                <label>54.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Saxton</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Ratcliff</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Munro</surname>
                      <given-names>CA</given-names>
                    </name>
                    <name>
                      <surname>Coffey</surname>
                      <given-names>EC</given-names>
                    </name>
                    <name>
                      <surname>Becker</surname>
                      <given-names>JT</given-names>
                    </name>
                    <name>
                      <surname>Fried</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Kuller</surname>
                      <given-names>L</given-names>
                    </name>
                  </person-group>
                  <article-title>Normative data on the Boston Naming Test and two equivalent 30-item short forms</article-title>
                  <source>Clin Neuropsychol</source>
                  <year>2000</year>
                  <volume>14</volume>
                  <issue>4</issue>
                  <fpage>526</fpage>
                  <lpage>534</lpage>
                  <pub-id pub-id-type="doi">10.1076/clin.14.4.526.7204</pub-id>
                  <?supplied-pmid 11262721?>
                  <pub-id pub-id-type="pmid">11262721</pub-id>
                </element-citation>
              </ref>
              <ref id="CR55">
                <label>55.</label>
                <mixed-citation publication-type="other">Schmidt M. Rey Auditory and Verbal Learning Test: A handbook: Western Psychological Services Los Angeles; 1996.</mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
